Vaccine and Treatments Evaluation Unit

Vaccine and Treatments Evaluation Unit
Name	Vaccine and Treatments Evaluation Unit
Formation	20XX
Type	Clinical research unit
Headquarters	London
Region served	International
Leader title	Director
Parent organization	National Institute for Health and Care Research

Vaccine and Treatments Evaluation Unit

The Vaccine and Treatments Evaluation Unit is a clinical research and trial coordination center that conducts evaluation of vaccines, therapeutics, and diagnostics for infectious diseases. It operates alongside institutions that include Wellcome Trust, National Institute for Health and Care Research, University of Oxford, Imperial College London, London School of Hygiene and Tropical Medicine and collaborates with global partners such as World Health Organization, Gavi, the Vaccine Alliance, Coalition for Epidemic Preparedness Innovations, European Medicines Agency and Pan American Health Organization.

History

The unit was established amid responses to outbreaks linked to organizations like Public Health England, Centers for Disease Control and Prevention, European Centre for Disease Prevention and Control and national programs inspired by programs from Department of Health and Social Care, National Institutes of Health and Biomedical Advanced Research and Development Authority. Early milestones involved partnerships with Medical Research Council, Wellcome Trust, Bill & Melinda Gates Foundation and collaborations with academic centers such as University College London, King's College London, University of Cambridge, Harvard T.H. Chan School of Public Health and Johns Hopkins Bloomberg School of Public Health. The unit's work drew on legacies from trials coordinated with Oxford Vaccine Group, NIHR Clinical Research Network, International Vaccine Institute, Institut Pasteur, and technical guidance from Food and Drug Administration and European Medicines Agency.

Mission and Objectives

The unit's mission aligns with priorities articulated by World Health Organization emergency committees, funding frameworks from Wellcome Trust and Bill & Melinda Gates Foundation, and strategic goals of National Institute for Health and Care Research and Department for International Development. Objectives include designing adaptive trials inspired by methods from RECOVERY Trial, harmonizing protocols with standards from International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, accelerating licensure pathways used by Food and Drug Administration and European Medicines Agency, and building capacity in regions served by Africa Centres for Disease Control and Prevention, Pan American Health Organization, Southeast Asian Regional Office, and World Bank health initiatives.

Organizational Structure

The unit is organized into clinical operations, biostatistics, laboratory sciences, regulatory affairs, data management, ethics, and patient engagement divisions modeled on structures in University of Oxford, Imperial College London, London School of Hygiene and Tropical Medicine and clinical research hubs like NIHR Clinical Research Network and MRC Clinical Trials Unit. Leadership interacts with advisory boards including experts from World Health Organization, European Medicines Agency, National Institutes of Health, Wellcome Trust, Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations and representatives from partner hospitals such as Guy's and St Thomas' NHS Foundation Trust, St George's University Hospitals NHS Foundation Trust, and international centers like Karolinska Institutet and Duke University School of Medicine.

Research and Evaluation Activities

Research activities include adaptive platform trials inspired by the RECOVERY Trial and Solidarity Trial, vaccine efficacy studies following frameworks used in Oxford-AstraZeneca vaccine development, therapeutic evaluations similar to trials for dexamethasone and antiviral agents like those studied for Ebola virus disease and COVID-19 pandemic responses. Laboratories collaborate with Institut Pasteur, University of Cambridge, Harvard Medical School, Scripps Research, The Francis Crick Institute and National Institute for Biological Standards and Control to validate assays, neutralization tests, and correlate immunogenicity parameters linked to approvals by European Medicines Agency and Food and Drug Administration. Biostatistics teams apply methods from Cohort Multiple Randomised Controlled Trial designs and work with groups at London School of Hygiene and Tropical Medicine, Johns Hopkins Bloomberg School of Public Health, and Emory University.

Regulatory and Ethical Oversight

Regulatory oversight is coordinated with agencies such as Medicines and Healthcare products Regulatory Agency, Food and Drug Administration, European Medicines Agency and regional regulators including Pan American Health Organization offices. Ethical review processes involve research ethics committees modeled after Research Ethics Committee structures used by University of Oxford and NHS Trusts, and participant protections informed by declarations and guidelines like Declaration of Helsinki and frameworks from Council for International Organizations of Medical Sciences. Data governance aligns with standards from General Data Protection Regulation, trial registration norms of International Committee of Medical Journal Editors and reporting practices advocated by CONSORT.

Collaborations and Partnerships

The unit partners with academic institutions including University of Oxford, Imperial College London, University College London, University of Cambridge, Harvard University, Johns Hopkins University, Karolinska Institutet, Duke University, McMaster University and with global health organizations such as World Health Organization, Gavi, the Vaccine Alliance, Coalition for Epidemic Preparedness Innovations, Wellcome Trust, Bill & Melinda Gates Foundation and funders like European Commission and UK Research and Innovation. Clinical sites include Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, Addenbrooke's Hospital, Royal Free Hospital, and international partners such as University Teaching Hospital Lusaka, Kenya Medical Research Institute, National Institute of Medical Research (Tanzania), and Oswaldo Cruz Foundation.

Impact and Notable Contributions

Notable contributions include conducting trials that informed therapeutic use of dexamethasone during the COVID-19 pandemic, participation in vaccine development pipelines alongside Oxford-AstraZeneca vaccine and trials contributing data used by European Medicines Agency and Food and Drug Administration. The unit's outputs influenced policy at World Health Organization emergency committees and supported procurement decisions by Gavi, the Vaccine Alliance and UNICEF. Publications and datasets have been cited by researchers at University of Oxford, Imperial College London, Harvard University, Johns Hopkins University and policy analyses by Lancet and New England Journal of Medicine.

Category:Clinical research organizations